
    
      The aim of the study is to determine objective anatomical recurrent prolapse after SLF vs
      McCall. The study is designed as a Randomized Controlled Trial (RCT). Primary study endpoint
      will be at 12 months, secondary study endpoint at 24 months. The following parameters will be
      evaluated after one year: anatomical outcome, Quality of Life (QoL), sexual health,
      reoperations, and complications.
    
  